🇰🇷 Winlevi in South Korea

MFDS authorised Winlevi on 26 August 2020

Marketing authorisation

MFDS — authorised 26 August 2020

  • Marketing authorisation holder: CASSIOPEA SPA
  • Status: likely_approved

Winlevi in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Dermatology approved in South Korea

Frequently asked questions

Is Winlevi approved in South Korea?

Yes. MFDS authorised it on 26 August 2020.

Who is the marketing authorisation holder for Winlevi in South Korea?

CASSIOPEA SPA holds the South Korean marketing authorisation.